Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

3 treatments under study, led by Microvascular Markers

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT06724861Not ApplicableRecruiting

Sensory Rehabilitation in Chemo Induced Peripheral Neuropathy

NCT03919474Completed

Blood Markers in Adult Patients With Sudden Sensorineural Hearing Loss (SSNHL)

Showing all 2 trials

Research Network

Common Treatments

  • Microvascular Markers1
  • No Treatment1
  • Explicit Sensory Retraining For The Lower Extremities1

Active Sponsors

  • Hopital Lariboisière1
  • Assaf-Harofeh Medical Center1
  • Zefat Academic College1

Top Investigators

Related Conditions

  • Idiopathic Ssnhl1
  • Chemotherapyinduced Peripheral Neuropathy1
  • Cipn Chemotherapyinduced Peripheral Neuropathy1

Activity Timeline